Blood Clot
Clot-retrieval device safe, effective for treatment of chronic thrombus in DVT at 30 days
A clot-removal device successfully removed chronic thrombus from patients with deep vein thrombosis and was associated with few adverse events at 30 days, researchers reported.
European regulators recommend adding blood clot warning to J&J vaccine
European regulators said Tuesday that a warning about unusual blood clots with low blood platelets should be added to information about the Johnson & Johnson COVID-19 vaccine but also that the benefits of the vaccine outweigh the risks.
CDC, FDA recommend pausing rollout of J&J vaccine over six blood clot cases
Federal health officials recommended Tuesday that the U.S. “pause” the rollout of Johnson & Johnson’s COVID-19 vaccine so experts can review six reported cases of a rare but severe type of blood clot in people who have received the vaccine.
Adjustable clot retriever improves reperfusion, outcomes in large vessel occlusion stroke
An adjustable clot retriever device for large vessel occlusion ischemic stroke was demonstrated to be both more effective and safer compared with prior data on other stent-retriever devices, a speaker reported.
Self-expanding venous stent receives FDA approval
Cook Medical announced its self-expanding venous stent received FDA premarket approval and is expected to be commercially available in the U.S. in the fourth quarter of 2020.
Mechanical thrombectomy system receives FDA clearance
Philips announced that a mechanical thrombectomy system to remove blood clots from vessels within the peripheral arterial and venous systems has received 510(k) clearance from the FDA and is now available in the U.S.
Research needed on pregnancy, hormonal birth control and blood clot risk in COVID-19
COVID-19 may increase the risk for blot clots in women who are pregnant or taking estrogen with birth control or hormone therapy, and more research is needed on the underlying mechanisms that could potentially drive risk, researchers wrote.
Aspiration system for peripheral thrombectomy launched after FDA clearance
Penumbra announced that it has launched its next-generation aspiration system for peripheral thrombectomy, which received FDA clearance in June.
Study identifies cardiopulmonary contributors to death in COVID-19
An autopsy study of African Americans who died from COVID-19 in New Orleans has revealed that certain pulmonary and cardiac pathology likely contributed to severe disease and death in this patient population.
FDA designates recall of balloon embolectomy catheter as class 1
The FDA has identified the recall of LeMaitre Vascular’s balloon embolectomy catheter as class 1, the most serious kind, due to risk for death or injury from balloon deflation failure.